Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
English Court of Appeal finds in favor of Teva on Copaxone(R) patent litigation and upholds validity of Copaxone patent until May 2015
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Stress and the risk of multiple sclerosis.
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis.
Shorter washout reduces MS relapse switching off natalizumab
Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab.
Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis
[Infections and fingolimod].
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Double blind placebo-controlled Phase I/II clinical trial of idebenone in patients with primary progressive multiple sclerosis (IPPoMS)
Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
Assessment of the effect of interferon-beta1a therapy on thyroid and salivary gland functions in patients with multiple sclerosis using quantitative salivary gland scintigraphyz.
ALAIN01-Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.
Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.

Pages